Home > Healthcare > Biotechnology > Biotechnology R&D > U.S. Bioreactors Market
U.S. Bioreactors Market Trends
- Report ID: GMI10829
- Published Date: Aug 2024
- Report Format: PDF
U.S. Bioreactors Market Trends
- The shift towards single-use bioreactors, which offer advantages such as reduced risk of cross-contamination, lower capital investment, and greater flexibility, is expected to significantly boost market growth. These features make single-use bioreactors particularly attractive for small-scale and multiproduct manufacturing facilities.
- Additionally, advancements in bioreactor technology, such as the integration of automation and real-time monitoring systems, are enhancing process efficiency and product quality.
- Furthermore, the escalating demand for biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell and gene therapies is a prominent trend. Given the complex cell culture processes these therapies entail, the market for advanced bioreactors has witnessed a notable upswing.
Frequently Asked Questions (FAQ) :
The U.S. bioreactors market size was valued at around USD 3.8 billion in 2023 and is estimated to grow at 11% CAGR from 2024 to 2032, driven by the growing demand for biopharmaceuticals.
The reusable bioreactors segment in the U.S. held a revenue of USD 2.8 billion in 2023 and will grow rapidly through 2032, owing to its cost-effectiveness.
The U.S. stainless-steel bioreactors segment held a decent market share in 2023 and is anticipated to account for USD 5.5 billion by 2032, owing to its durability and robustness.
Aledade, Ariadne Labs , MyDirectives, Inc, Respecting Choices, Sharp HealthCare, VyncaCare, WiserCare among others.
U.S. Bioreactors Market Scope
×
Get a free sample of
U.S. Bioreactors Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below